LPS interactions with immobilized and soluble antimicrobial peptides

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 70, Issue 3, 2010, Pages 194-200

  Gustafsson, Anna ^a   Olin, Anders I ^b   Ljunggren, Lennart ^a  

^a MALMÖ UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Cationic peptides; ELISA; Limulus test; Sepsis; Surface plasmon resonance

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; PEPTIDE BPI; PEPTIDE CEME; PEPTIDE S3DELTA; PEPTIDE SC4; PLASMA PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; HUMAN; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; PROTEIN LIPID INTERACTION; SEPSIS;

ADSORPTION; AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; CYTOKINES; HUMANS; IMMOBILIZED PROTEINS; ISOELECTRIC POINT; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; SOLUBILITY; SURFACE PLASMON RESONANCE;

BACTERIA (MICROORGANISMS); LIMULUS; MAMMALIA;

EID: 77951490780     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365511003663622     Document Type: Article

References (25)

1. Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885-891
2. Lepper PM, Held TK, Schneider EM, Bolke E, Gerlach H, Trautmann M. Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Med 2002;28:824-833
3. Andra J, Gutsmann T, Garidel P, Brandenburg K. Mechanisms of endotoxin neutralization by synthetic cationic compounds. J Endotoxin Res 2006;12:261-277
4. Brown KL, Hancock RE. Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 2006;18:24-30
5. Kamysz W. Are antimicrobial peptides an alternative for conventional antibiotics? Nucl Med Rev Cent East Eur 2005;8:78-86
6. Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K, Nakae H, Endo S. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Ther Apher Dial 2006;10: 12-18
7. Hanasawa K. Extracorporeal treatment for septic patients: new adsorption technologies and their clinical application. Ther Apher 2002;6:290-295
8. Shimizu T, Endo Y, Tsuchihashi H, Akabori H, Yamamoto H, Tani T. Endotoxin apheresis for sepsis. Transfus Apher Sci 2006;35:271-282
9. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009; 301:2445-2452
10. Scott MG, Gold MR, Hancock RE. Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect Immun 1999;67:6445-6453
11. Nell MJ, Tjabringa GS, Wafelman AR, Verrijk R, Hiemstra PS, Drijfhout JW, Grote JJ. Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 2006;27:649-660
12. Lockwood NA, Haseman JR, Tirrell MV, Mayo KH. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains. Biochem J 2004;378:93-103
13. Ding JL, Zhu Y, Ho B. High-performance affinity captureremoval of bacterial pyrogen from solutions. J Chromatogr B Biomed Sci Appl 2001;759:237-246
14. Farley MM, Shafer WM, Spitznagel JK. Lipopolysaccharide structure determines ionic and hydrophobic binding of a cationic antimicrobial neutrophil granule protein. Infect Immun 1988;56:1589-1592
15. Goh YY, Frecer V, Ho B, Ding JL. Rational design of green fluorescent protein mutants as biosensor for bacterial endotoxin. Protein Eng 2002;15:493-502
16. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-395
17. Ciornei CD, Sigurdardottir T, Schmidtchen A, Bodelsson M. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother 2005;49:2845-2850
18. Scott MG, Yan H, Hancock RE. Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect Immun 1999;67:2005-2009
19. Ding JL, Ho B. A new era in pyrogen testing. Trends Biotechnol 2001;19:277-281
20. Nilsson A, Fant C, Nyden M, Holmberg K. Lipopolysaccharide removal by a peptide-functionalized surface. Colloids Surf B Biointerfaces 2005;40:99-106
21. Santos NC, Silva AC, Castanho MA, Martins-Silva J, Saldanha C. Evaluation of lipopolysaccharide aggregation by light scattering spectroscopy. Chembiochem 2003;4:96-100
22. Mayo KH, Haseman J, Young HC, Mayo JW. Structurefunction relationships in novel peptide dodecamerswith broad-spectrum bactericidal and endotoxin-neutralizing activities. Biochem J 2000;349 Pt 3:717-728
23. Behre G, Schedel I, Nentwig B, Wormann B, Essink M, Hiddemann W. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins. Antimicrob Agents Chemother 1992;36:2139-2146
24. Gutsmann T, Howe J, Zahringer U, Garidel P, Schromm AB, Koch MHJ, Fujumoto Y, Fukase K, Moriyon I, Martinez-de-Tejada G, Brandenburg K. Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells. Innate Immun 2010;16:39-47
25. Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis 2002;2:171-179